Portfolio company
Instylla
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops resorbable liquid embolic agents used by interventional radiologists to treat hypervascular tumours and peripheral vascular conditions.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
LaNua Medical
This company develops embolisation devices that block blood flow in vessels to treat tumours and internal bleeding for radiologists and surgeons.
LaNua
This company develops endovascular devices for embolisation procedures to help radiologists and surgeons treat tumours, internal bleeding, and vascular malformations.
Agile Devices
This company develops steerable microcatheters for interventional radiologists and cardiologists to navigate complex blood vessels during vascular procedures.
ENDOVASCULAR DEVICES
This company develops minimally invasive vessel preparation tools to treat peripheral artery disease and failed arteriovenous fistulas for interventional clinicians.
Okami Medical
This company develops catheter-based vascular occlusion devices to obstruct blood flow in peripheral vessels for patients and interventional physicians.
Intelvasc
This company develops implantable sensors and monitoring systems to track blood flow and vascular occlusions for patients with peripheral arterial disease.
Imperative Care
This company develops thrombectomy systems and digital health tools to treat patients suffering from strokes and other vascular diseases.
nextbiomedical
This company manufactures resorbable microspheres and embolic agents for clinical teams performing endovascular embolisation and musculoskeletal pain management procedures.
